Tailoring antifungal doses for seniors: a precision approach
NCT ID NCT07496008
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find the best dose of isavuconazole, an antifungal drug, for patients over 60 with invasive fungal infections. Researchers will monitor drug levels in the blood and adjust doses to improve treatment and reduce side effects. The goal is to create personalized dosing guidelines for this older population.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
isavuconazole
What this could lead to
If successful, this could lead to safer, more effective dosing guidelines for isavuconazole in older adults with invasive fungal infections.
What could go wrong
This is an early-stage observational study, not a large treatment trial. Results may not change current practice, and individual responses can vary widely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCORMYCOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••